Cargando…

P.0370 Escitalopram efficacy in post-covid depression treatment: a pilot study

Detalles Bibliográficos
Autores principales:	Chaban, O., Khaustova, O., Assonov, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716255/ http://dx.doi.org/10.1016/j.euroneuro.2021.10.350

Ejemplares similares

COVID-19 pandemic’s burden on healthcare professionals’ mental health
por: Khaustova, O., et al.
Publicado: (2021)

SP-0370 ESTRO RTTC guidance on COVID-19
por: Rossi, M.
Publicado: (2021)

Combined therapy of positive interventions and cognitive training for reducing neurobehavioral symptoms of traumatic brain injury: A clinical case
por: Khaustova, O., et al.
Publicado: (2021)

P.0504 Cognitive impairment in in-patients with COVID-19 pneumonia
por: Chaban, O., et al.
Publicado: (2021)

EHMTI-0370. The performance of the ID-Migraine questionnaire in a Hungarian sample
por: Csepany, E, et al.
Publicado: (2014)

Efficacy of escitalopram oxalate for patients with post-stroke depression
por: Xu, Ji-hua, et al.
Publicado: (2018)

P.0808 Mental health status of medical doctors during COVID-19 epidemic in Ukraine
por: Frankova, I., et al.
Publicado: (2021)

IDF21-0370 New forms of diabetic education during the COVID-19 pandemic
por: Bukovská, A.
Publicado: (2022)

Clinical efficacy of Vortioxetine and escitalopram in the treatment of depression
por: Shao, Shichuan, et al.
Publicado: (2022)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
por: Ali, Mazen K, et al.
Publicado: (2011)

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Unraveling the Potential of Isorhamnetin as an Adjuvant in Depression Treatment with Escitalopram
por: Gammoh, Omar, et al.
Publicado: (2023)

Efficacy of escitalopram for poststroke depression: a systematic review and meta-analysis
por: Feng, Rong-fang, et al.
Publicado: (2022)

Serotonin transporter gene polymorphism and treatment response to serotonin reuptake inhibitor (escitalopram) in depression: An open pilot study
por: Margoob, Mushtaq A., et al.
Publicado: (2008)

Regional White Matter Integrity Predicts Treatment Response to Escitalopram and Memantine in Geriatric Depression: A Pilot Study
por: Krause-Sorio, Beatrix, et al.
Publicado: (2020)

Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study
por: Wade, Alan G, et al.
Publicado: (2011)

Chronic P‐glycoprotein inhibition increases the brain concentration of escitalopram: potential implications for treating depression
por: O'Brien, Fionn E., et al.
Publicado: (2015)

Mild cognitive disorder and depression: treatment with combination of galantamine and escitalopram
por: Zarra, Julio, et al.
Publicado: (2010)

Efficacy of hyperbaric oxygen combined with escitalopram in depression and its effect on cognitive function
por: Mi, Kun, et al.
Publicado: (2021)

Depression in Acromegaly Treated with Escitalopram and Cognitive Therapy
por: De Sousa, Avinash
Publicado: (2009)

Spatio-temporal dynamics of EEG features during sleep in major depressive disorder after treatment with escitalopram: a pilot study
por: Wu, Li, et al.
Publicado: (2020)

Efficacy and safety of generic escitalopram (Lexacure(®)) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study
por: Jeong, Jong-Hyun, et al.
Publicado: (2015)

Publisher Correction: Efficacy of escitalopram for poststroke depression: a systematic review and meta-analysis
por: Feng, Rong-fang, et al.
Publicado: (2022)

Clinical efficacy and safety of Guipi decoction combined with escitalopram oxalate tablets in patients with depression
por: Yu, Jia, et al.
Publicado: (2023)

CYP2D6 P34S Polymorphism and Outcomes of Escitalopram Treatment in Koreans with Major Depression
por: Han, Kyu-Man, et al.
Publicado: (2013)

Escitalopram/midazolam: Lack of efficacy: case report
Publicado: (2022)

Efficacy of escitalopram monotherapy in the treatment of major depressive disorder: A pooled analysis of 4 Chinese clinical trials
por: Li, Guanjun, et al.
Publicado: (2017)

Sexual functioning in females with depression in remission receiving escitalopram
por: Roy, Pritha, et al.
Publicado: (2019)

Effects of fluoxetine and escitalopram on C-reactive protein in patients of depression
por: Chavda, Nilesh, et al.
Publicado: (2011)

A pilot study on improvements in attention function in major depressive disorder after 12 weeks of escitalopram monotherapy or combined treatment with agomelatine
por: Li, Zhe, et al.
Publicado: (2023)

Comparing the Therapeutic Effects of Crocin, Escitalopram and Co-Administration of Escitalopram and Crocin on Learning and Memory in Rats with Stress-Induced Depression
por: Joodaki, Mehran, et al.
Publicado: (2021)

Characterization of gut microbiome in mice model of depression with divergent response to escitalopram treatment
por: Duan, Jiajia, et al.
Publicado: (2021)

The Relationship Between Theta Power, Theta Asymmetry and the Effect of Escitalopram in the Treatment of Depression
por: Gao, Min, et al.
Publicado: (2023)

Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability
por: Kirino, Eiji
Publicado: (2012)

Efficacy and tolerability of Escitalopram in patients with chronic kidney disease undergoing hemodialysis having depressive disorder
por: Naik1, Bhavyashree Laxman, et al.
Publicado: (2022)

Two-Step Resilience-Oriented Intervention for Veterans with Traumatic Brain Injury: A Pilot Randomized Controlled Trial
por: Assonov, Dmytro
Publicado: (2021)

Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study
por: Hart, Xenia M., et al.
Publicado: (2023)

Comparative safety and efficacy of tibolone and escitalopram in postmenopausal women
por: Raj, Rajnish, et al.
Publicado: (2021)

PS85. Efficacy and Safety of Generic Escitalopram (Lexacure) in Patients with Major Depressive Disorder: A 6-week, Multi-center, Randomized, Rater-blinded, Escitalopram-comparative, Non-inferiority Study
por: Jeong, Jong-Hyun, et al.
Publicado: (2016)

Effect of Escitalopram on White Blood Cells in Patients With Major Depression
por: Canan, Fatih, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ctdcttas218lhj1nct5oq9iquk